Natalizumab
Cat. No. :YN300013
CAS No. :189261-10-7
86-020-82000279
sales@ubiochem.com
order@ubiochem.com| Product Name: | Natalizumab |
| CAS NO.: | 189261-10-7 |
| Chemical Name: | |
| Synonyms: | |
| Molecular Weight: | 无Molecular Weight |
| Molecular Formula: | 无Formula |
| SMILES: | [Natalizumab] |
| Storage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Transportation: | Room temperature in continental US; may vary elsewhere. |
| Description: | Natalizumab is a recombinant, humanized monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses. |
| IC50&Target: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | |
| References: |
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.
